Drug Shortage Report for IBAVYR

Last updated on 2020-03-11 History
Report ID 101774
Drug Identification Number 02439212
Brand name IBAVYR
Common or Proper name ribavirine USP
Company Name PENDOPHARM DIVISION OF PHARMASCIENCE INC
Market Status DORMANT
Active Ingredient(s) RIBAVIRIN
Strength(s) 200MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100 tabs
ATC code J05AP
ATC description
Reason for shortage Demand increase for the drug.
Anticipated start date 2019-12-19
Actual start date
Estimated end date 2020-01-17
Actual end date 2020-01-20
Shortage status Resolved
Updated date 2020-03-11
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 6111 ROYALMOUNT AVE
MONTREAL, QUEBEC
CANADA H4P 2T4
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2020-03-11 French Compare
v4 2020-03-11 English Compare
v3 2019-12-20 English Compare
v2 2019-12-19 French Compare
v1 2019-12-19 English Compare

Showing 1 to 5 of 5